SCHEMBL29930701

SCHEMBL29930701

COc1ccc(-c2n[nH]c3ncc(Nc4ccccc4)cc23)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 7/20 0.67
DYRK1A Q13627 6/20 0.67
MAPT P10636 2/20 0.46
MAPK1 P28482 2/20 0.46
LMNA P02545 1/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
ACP1 P24666 1/20 0.45
GSK3B P49841 1/20 0.45
MAPK10 P53779 1/20 0.45
MAPK14 Q16539 1/20 0.45
DHFR P00374 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA2B P29275 1/20 0.44
BRAF P15056 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930889 0.88 DYRK1B (0.69) DYRK1BDYRK1AMAPTMAPK1LMNA
SCHEMBL29930670 0.87 DYRK1B (0.70) DYRK1BDYRK1ANPC1RAB9AGSK3B
SCHEMBL29930851 0.87 DYRK1B (0.73) DYRK1BDYRK1AMAPTMAPK1LMNA
SCHEMBL29930804 0.82 DYRK1A (0.70) DYRK1BDYRK1AMAPTMAPK1MEN1
SCHEMBL29930702 0.78 DYRK1B (0.73) DYRK1BDYRK1AMAPT
SCHEMBL28562998 0.78 DYRK1B (0.61) DYRK1BDYRK1AMAPTMAPK1MEN1
SCHEMBL29930500 0.78 DYRK1A (0.47) DYRK1BDYRK1AMAPTMAPK1MEN1
SCHEMBL29930763 0.77 DYRK1B (0.71) DYRK1BDYRK1AMAPTMEN1NPC1
SCHEMBL6684639 0.74 LMNA (0.57) DYRK1BDYRK1AMAPTMAPK1LMNA
SCHEMBL29930898 0.73 DYRK1A (0.65) DYRK1BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO claimed
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed